![Peter A. Friedli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter A. Friedli
Fondateur chez
NEW VENTURETEC AG
Profil
Peter A. Friedli is the founder of Osiris Therapeutics, Inc. (founded in 1992) where he served as Chairman from 1992 to 2019.
He is also the founder of Invenda Corp.
(founded in 1996) where he currently holds the position of Director.
Additionally, he is the founder of New Venturetec AG (founded in 1997) where he currently holds the position of Chairman and Chairman of the Board of Directors.
Mr. Friedli's current job(s) include being a Director at Vertical Circuits, Inc. and a Director at Prolexys Pharmaceuticals, Inc.Mr. Friedli's former job(s) include being the Chief Executive Officer at Pine Investments AG (from 1986 to 2012), Chairman at Inflabloc Pharmaceuticals, Inc., Chairman at ReVerb Networks, Inc., Director at mPortal, Inc., and President at Venturetec, Inc.
Postes actifs de Peter A. Friedli
| Sociétés | Poste | Début |
|---|---|---|
| NEW VENTURETEC AG | Fondateur | 16/07/1997 |
Invenda Corp.
 Invenda Corp. Advertising/Marketing ServicesCommercial Services Provides interactive marketing technologies and services via the Internet | Fondateur | 01/01/1996 |
Prolexys Pharmaceuticals, Inc.
 Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Vertical Circuits, Inc.
 Vertical Circuits, Inc. SemiconductorsElectronic Technology Manufactures semiconductors and electronic capacitors | Directeur/Membre du Conseil | - |
New Venturetec AG /Venture Capital/
 New Venturetec AG /Venture Capital/ Investment ManagersFinance New Venturetec invests in private, public companies and in all classes of securities, including common and preferred equity, secured and unsecured debt, convertibles, options, warrants and combinations thereof. The firm focuses on companies operating in the fields of biotechnology and technology. It provides financing for all stages from seed to late stage. | Fondateur | 08/08/1997 |
Anciens postes connus de Peter A. Friedli
| Sociétés | Poste | Fin |
|---|---|---|
| OSIRIS THERAPEUTICS, INC. | Fondateur | 17/04/2019 |
Pine Investments AG
 Pine Investments AG Investment ManagersFinance Friedli CF aims to identify, structure, launch and manage businesses which they perceive as likely to reach the technology forefront over the next decade. The firm has invested venture capital in the biotechnology, computer technology, communications and Internet technology sectors, predominantly in the US. Friedli CF selects investments after an in-depth analysis of people, technology and potential markets, with a particularly focus on the capabilities and commitment of the management team. The firm follows a hands-on approach and influences key management and strategic decisions. They set milestones to be reached, closely monitor company development and conduct periodical management reviews. | President | 13/08/2012 |
ReVerb Networks, Inc.
 ReVerb Networks, Inc. BroadcastingConsumer Services Develops and designs an integrated radio and antenna systems | Président | - |
mPortal, Inc.
 mPortal, Inc. Packaged SoftwareTechnology Services Designs and develops mobile content and applications | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Osiris Therapeutics, Inc.
 Osiris Therapeutics, Inc. BiotechnologyHealth Technology Researches and develops therapeutic products for the regeneration of human connective tissues | Health Technology |
Invenda Corp.
Invenda Corp. Advertising/Marketing ServicesCommercial Services Provides interactive marketing technologies and services via the Internet | Commercial Services |
Venturetec, Inc. | |
New Venturetec AG
 New Venturetec AG Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Inflabloc Pharmaceuticals, Inc.
 Inflabloc Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of pharmaceutical treatments | Commercial Services |
Vertical Circuits, Inc.
Vertical Circuits, Inc. SemiconductorsElectronic Technology Manufactures semiconductors and electronic capacitors | Electronic Technology |
Prolexys Pharmaceuticals, Inc.
Prolexys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
mPortal, Inc.
mPortal, Inc. Packaged SoftwareTechnology Services Designs and develops mobile content and applications | Technology Services |
Pine Investments AG
Pine Investments AG Investment ManagersFinance Friedli CF aims to identify, structure, launch and manage businesses which they perceive as likely to reach the technology forefront over the next decade. The firm has invested venture capital in the biotechnology, computer technology, communications and Internet technology sectors, predominantly in the US. Friedli CF selects investments after an in-depth analysis of people, technology and potential markets, with a particularly focus on the capabilities and commitment of the management team. The firm follows a hands-on approach and influences key management and strategic decisions. They set milestones to be reached, closely monitor company development and conduct periodical management reviews. | Finance |
ReVerb Networks, Inc.
ReVerb Networks, Inc. BroadcastingConsumer Services Develops and designs an integrated radio and antenna systems | Consumer Services |
New Venturetec AG /Venture Capital/
New Venturetec AG /Venture Capital/ Investment ManagersFinance New Venturetec invests in private, public companies and in all classes of securities, including common and preferred equity, secured and unsecured debt, convertibles, options, warrants and combinations thereof. The firm focuses on companies operating in the fields of biotechnology and technology. It provides financing for all stages from seed to late stage. | Finance |
